Direxion Daily S&P Biotech Bear 3X ETF (LABD) price, chart and fund profile
Price chart
Fund profile
LABD provides daily 3 times inverse exposure to the S&P Biotechnology Select Industry Index.
- Issuer
- Rafferty Asset Management, LLC
- Industry
- Healthcare
- Inception
- May 28, 2015
- Assets under management
- $84.9M
- Expense ratio
- 1.07%
- Net asset value
- $6.63
- NAV as of
- Aug 28, 2026
- Leverage
- 3×
- Fund page
- www.direxioninvestments.com↗
Frequently asked questions
What is Direxion Daily S&P Biotech Bear 3X ETF (LABD)?
LABD provides daily 3 times inverse exposure to the S&P Biotechnology Select Industry Index.
What is LABD's expense ratio?
Direxion Daily S&P Biotech Bear 3X ETF charges an annual expense ratio of 1.07%. The fund is issued by Rafferty Asset Management, LLC.
How large is LABD?
Direxion Daily S&P Biotech Bear 3X ETF manages $84.9M in assets and has traded since May 28, 2015.
How do I buy shares of Direxion Daily S&P Biotech Bear 3X ETF (LABD)?
LABD trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web dashboard at portal.lighthorse.io, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.
Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.